CKD Intercept

Leadership Summits

The National Kidney Foundation is advancing a Collective Impact model to develop and advance equitable solutions to improve CKD testing and diagnosis in primary care.*

Doctors siting and listening to a speaker
Doctor listening and speaking with a patient

The State of CKD Care in the US

90% of people with kidney disease remain undiagnosed. Most people at risk for chronic kidney disease (CKD) do not receive the recommended testing. African Americans, Hispanics, Native Americans, and other communities of color are disproportionately affected by CKD and significant disparities in care exist in these communities. Social determinants, including economic insecurity, food insecurity, and limited access to quality care, contribute to the challenges faced by people living with kidney disease.


Icon of a group of people at meeting

Join Our Solution

Recognizing that a community-based, multi-dimensional approach is necessary to overcome these challenges, the National Kidney Foundation is advancing a Collective Impact strategy to develop and advance equitable solutions to improve CKD testing and diagnosis in primary care. These Ending Disparities in CKD Leadership Summits will convene stakeholders to participate in a series of “Learning and Action Workgroup” meetings. Read how we have demonstrated success in generated urgency and engaging partners to action here.
For more information contact Katelyn Engel Laue at

Ending Disparities in CKD throughout the USA:

   States that have launched
   Coming soon

Through the Learning and Action Workgroups participants will:

Analyze the prevalence of undiagnosed chronic kidney disease (CKD) in the state and its impact on patient outcomes, healthcare costs and health inequities.

Discuss strategies and approaches that can be employed to improve CKD recognition and care in primary care settings.

Evaluate the impact quality measures can have on improving breakdowns in care and develop a strategy to streamline CKD testing in primary care from a policy and payment perspective.

Develop a strategy to incorporate CKD testing and diagnosis into community wellness and prevention practices.

Develop strategies to advance CKD awareness through community engagement and to ensure that health care providers are aware of the community resources available to delay CKD progression.

Medical devices used by primary care doctors

After the Learning and Action Workgroups:

  • NKF and stakeholders will develop a local road map to drive a cultural shift in primary care — toward increasing the early diagnosis and management of CKD, especially in communities where the burden of CKD is felt most acutely.
  • Following these meetings, NKF works with local partners to advance local changes based on the goals identified: CKD screening and diagnosis practice improvement, access to CKD education and quality treatment, and/or transplant and home dialysis access for patients.
  • Data from local payers, laboratories, and other CKD surveillance sources will be used to monitor progress.


  • Collective impact is a model used to engage stakeholders from disparate fields to solve complex social problems that may be challenging to address by one organization alone.
  • Kania J, Kramer M. Collective impact. Stanford Social Innovation Review 2011; 9(1), 36–41. doi:10.48558/5900-KN19. Published 2011. Accessed November 3, 2022.

Kidney Equity for All logo

This program is an example of our multifaceted efforts in upholding an unwavering commitment towards achieving KIDNEY EQUITY FOR ALL.